Total Payments
$15,134
2024 Payments
$16.09
Companies
6
Transactions
57
Medicare Patients
419
Medicare Billing
$52,737
Payment Breakdown by Category
Consulting$7,425 (49.1%)
Research$3,663 (24.2%)
Travel$2,497 (16.5%)
Food & Beverage$1,549 (10.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,425 | 2 | 49.1% |
| Unspecified | $3,663 | 23 | 24.2% |
| Travel and Lodging | $2,497 | 8 | 16.5% |
| Food and Beverage | $1,549 | 24 | 10.2% |
Payments by Type
General
$11,471
34 transactions
Research
$3,663
23 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $8,500 | 24 | $0 (2020) |
| Travere Therapeutics, Inc. | $4,518 | 10 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,190 | 11 | $0 (2023) |
| Gilead Sciences, Inc. | $868.27 | 10 | $0 (2019) |
| Vertex Pharmaceuticals Incorporated | $42.00 | 1 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $16.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.09 | 1 | Aurinia Pharma U.S., Inc. ($16.09) |
| 2023 | $3,932 | 13 | Travere Therapeutics, Inc. ($2,700) |
| 2022 | $1,818 | 9 | Travere Therapeutics, Inc. ($1,818) |
| 2020 | $4,725 | 1 | GlaxoSmithKline, LLC. ($4,725) |
| 2019 | $2,780 | 20 | GlaxoSmithKline, LLC. ($1,912) |
| 2018 | $1,604 | 10 | GlaxoSmithKline, LLC. ($1,604) |
| 2017 | $259.12 | 3 | GlaxoSmithKline, LLC. ($259.12) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/09/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/31/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $42.00 | General |
| 08/29/2023 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $350.65 | General |
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $87.95 | General |
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $79.52 | General |
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $64.95 | General |
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $33.83 | General |
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $33.83 | General |
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $19.20 | General |
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $2.93 | General |
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $2.56 | General |
| 01/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $325.48 | General |
| 01/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $189.10 | General |
| 10/01/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | Cash or cash equivalent | $49.98 | General |
| 10/01/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | Cash or cash equivalent | $46.48 | General |
| 10/01/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.98 | General |
| 10/01/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.98 | General |
| 09/30/2022 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $946.45 | General |
| 09/30/2022 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $299.99 | General |
| 09/30/2022 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $257.30 | General |
| 09/30/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | Cash or cash equivalent | $129.99 | General |
| 09/21/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $37.50 | General |
| 02/03/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,725.00 | General |
| 11/05/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $201.89 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P | GlaxoSmithKline, LLC. | $2,795 | 13 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease | Gilead Sciences, Inc. | $868.27 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 205 | 319 | $101,406 | $24,698 |
| 2022 | 7 | 214 | 366 | $118,751 | $28,039 |
Total Patients
419
Total Services
685
Medicare Billing
$52,737
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 149 | $37,333 | $8,731 | 23.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 56 | $26,440 | $5,119 | 19.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $8,550 | $2,796 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 22 | $7,700 | $2,431 | 31.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 24 | $8,717 | $2,147 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 22 | $5,500 | $1,981 | 36.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 21 | 28 | $7,166 | $1,494 | 20.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 55 | 134 | $46,560 | $10,436 | 22.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 60 | 109 | $26,365 | $5,915 | 22.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 35 | $15,981 | $3,599 | 22.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 27 | 51 | $12,633 | $2,880 | 22.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $7,125 | $2,584 | 36.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $7,337 | $1,517 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $2,750 | $1,108 | 40.3% |
About Dr. Jeffrey Connaire, MD
Dr. Jeffrey Connaire, MD is a Nephrology healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710931449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Connaire, MD has received a total of $15,134 in payments from pharmaceutical and medical device companies, with $16.09 received in 2024. These payments were reported across 57 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($7,425).
As a Medicare-enrolled provider, Connaire has provided services to 419 Medicare beneficiaries, totaling 685 services with total Medicare billing of $52,737. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Minneapolis, MN
- Active Since 05/19/2006
- Last Updated 10/04/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1710931449
Products in Payments
- LUPKYNIS (Drug) $16.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Minneapolis
Kirsten Johansen, Md, MD
Nephrology — Payments: $134,524
Nephrology $134,524
Dr. Jeffrey Kohen, M.d, M.D
Nephrology — Payments: $101,893
Nephrology $101,893
Dr. James Wetmore, Md, MD
Nephrology — Payments: $49,852
Nephrology $49,852
Dr. Robert Foley, Mb, MB
Nephrology — Payments: $27,301
Nephrology $27,301
Keith Eidman, Do, DO
Nephrology — Payments: $8,274
Nephrology $8,274
Dr. Patrick Nachman, Md, MD
Nephrology — Payments: $8,225
Nephrology $8,225